EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders

Sherri L LaVela iD, Kelsey Berryman iD, Ibuola Kale iD, Gary J Farkas iD, Geoffrey V Henderson iD, Vanessa Rosales iD, Dan Eisenberg iD, Lorena Reyes iD

Obesity Science & Practice · 2024-08 · 10 (4)

DOI: 10.1002/osp4.784 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Obesity Science & Practice, online erschienen am 13.08.2024. Verfasst von Sherri L LaVela und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterans Affairs Center of Innovation for Complex Chronic Healthcare (CINCCH) Edward Hines Jr. VA Hospital Hines Illinois USA. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: U.S. Department of Veterans Affairs, Health Services Research and Development.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Anti‐obesity medications (AOMs) may provide a viable option for obesity management. However, little is known about the use of AOMs in persons with SCI/D.

Objective

Describe health care providers' (HCPs) views about barriers to AOM use in persons living with SCI/D.

Methods

Descriptive qualitative design using in‐depth interviews Descriptive statistics were used to calculate demographic and employment characteristics. Interviews were audio‐recorded and transcribed verbatim. Transcripts were coded and analyzed using Braun and Clarke's (2006) six thematic analysis phases.

Results

HCPs (n = 12) were from 11 different nationwide facilities. Most HCPs were male (75%), a large majority were white (67%), and most were 26–49 years of age. Participants were dietitians (75%), physicians (17%), and psychologists (8%). HCPs ranged from 1.5 to 15 years of providing SCI/D care. HCPs described four main thematic barriers to AOM use in persons with SCI/D: (1) AOM side effects that are especially concerning in persons with SCI/D; (2) AOMs contribute to poor eating habits; (3) availability, accessibility, and administration; and (4) lack of evidence, clinical agreement, and knowledge about AOM use in the SCI/D population.

Conclusions

There are several potential barriers to AOM use in the SCI/D population. Barriers include AOM side effects which may cause or exacerbate conditions that are already concerns in persons with SCI/D, such as bowel and skin problems, and muscle loss. SCI/D HCPs reported a lack of evidence about AOM use in persons with SCI/D, but interest in obtaining more knowledge.

Schlagwörter

Stichwörter der Autor:innen

anti‐obesity medicationhcpobesitypharmacotherapyqualitativespinal cord injury

Autor:innen und Institutionen

  • Department of Veterans Affairs Center of Innovation for Complex Chronic Healthcare (CINCCH) Edward Hines Jr. VA Hospital Hines Illinois USA.
  • Department of Physical Medicine and Rehabilitation Feinberg School of Medicine Northwestern University Chicago Illinois USA.
  • Department of Physical Medicine and Rehabilitation University of Miami Miller School of Medicine Miami Florida USA.
  • Miami Project to Cure Paralysis University of Miami Miller School of Medicine Miami Florida USA.
  • Department of Physical Medicine and Rehabilitation SUNY Upstate Medical University Syracuse New York USA.
  • Center for Innovation to Implementation VA Palo Alto Health Care System Palo Alto California USA.

ORCID-Profile: Sherri L LaVela, Kelsey Berryman, Ibuola Kale, Gary J Farkas, Geoffrey V Henderson, Vanessa Rosales, Dan Eisenberg, Lorena Reyes

Förderung

  • U.S. Department of Veterans Affairs
  • Health Services Research and Development

Zitieren

APA

LaVela, S. L., Berryman, K., Kale, I., Farkas, G. J., Henderson, G. V., Rosales, V., Eisenberg, D., & Reyes, L. (2024). Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders. Obesity Science & Practice, 10(4). https://doi.org/10.1002/osp4.784

Vancouver

LaVela SL, Berryman K, Kale I, Farkas GJ, Henderson GV, Rosales V, et al. Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders. Obesity Science & Practice. 2024;10(4). doi:10.1002/osp4.784

BibTeX
@article{LaVela2024,
  author = {LaVela, Sherri L and Berryman, Kelsey and Kale, Ibuola and Farkas, Gary J and Henderson, Geoffrey V and Rosales, Vanessa and Eisenberg, Dan and Reyes, Lorena},
  title = {Potential barriers to the use of anti‐obesity medications in persons with spinal cord injuries and disorders},
  journal = {Obesity Science & Practice},
  year = {2024},
  volume = {10},
  number = {4},
  doi = {10.1002/osp4.784}
}
Kostenlos starten →